Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,356
datasets available to search
ShareScore release 0.9.0
Dataset results
10,356 results for “Severity”
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
ClinicalTrials.gov study NCT03417245. IPD Sharing: YES. Countries: 19. Publications: 2.
Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03774082. IPD Sharing: YES. Countries: 14. Publications: 1.
The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma
ClinicalTrials.gov study NCT04400318. IPD Sharing: YES. Countries: 13. Publications: 2.
Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants
ClinicalTrials.gov study NCT03387852. IPD Sharing: YES. Countries: 8. Publications: 2.
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
ClinicalTrials.gov study NCT02400476. IPD Sharing: YES. Countries: 7. Publications: 2.
An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A
ClinicalTrials.gov study NCT02234323. IPD Sharing: YES. Countries: 14. Publications: 2.
Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab
ClinicalTrials.gov study NCT01544595. IPD Sharing: UNDECIDED. Countries: 26. Publications: 1.
Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis
ClinicalTrials.gov study NCT02471144. IPD Sharing: YES. Countries: 19. Publications: 2.
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT03653026. IPD Sharing: YES. Countries: 44. Publications: 9.
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
ClinicalTrials.gov study NCT05421598. IPD Sharing: YES. Countries: 14. Publications: 0.
A Phase 3 Open-label Interventional Study of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein, Efanesoctocog Alfa (BIVV001), in Patients With Severe Hemophi
ClinicalTrials.gov study NCT04161495. IPD Sharing: YES. Countries: 19. Publications: 5.
Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss
ClinicalTrials.gov study NCT02132130. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Respiratory Exacerbation Plans for Action and Care Transitions for Children With Severe CP
ClinicalTrials.gov study NCT05292365. IPD Sharing: YES. Countries: 1. Publications: 2.
An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B
ClinicalTrials.gov study NCT02554773. IPD Sharing: YES. Countries: 5. Publications: 1.
Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures
ClinicalTrials.gov study NCT01913405. IPD Sharing: YES. Countries: 9. Publications: 1.
Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT04999839. IPD Sharing: YES. Countries: 2. Publications: 1.
Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)
ClinicalTrials.gov study NCT03713632. IPD Sharing: YES. Countries: 32. Publications: 5.
Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03912259. IPD Sharing: YES. Countries: 1. Publications: 1.
Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03668613. IPD Sharing: YES. Countries: 9. Publications: 4.
This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).
ClinicalTrials.gov study NCT03713619. IPD Sharing: YES. Countries: 29. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.